Stock listing

Stockholm:SIMRISB Simris Group AB Aktie

Home listing (Stockholm) of Simris Group AB

Follow Simris Group AB into a list and get an email when it puts out news.

Share price · OMXSTO:SIMRIS_B

0.087 SEK -0.009 (-9.0%)

Close on Nov 20, 2026

Past year -12.6% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
0.080 – 0.095 SEKNov 20, 2026
Volume
11,935 sharesNov 20, 2026
Market cap
118.0M SEKAt the close on Nov 20, 2026 · price × 1.35B shares outstanding
52-week range
0.040 – 0.195 SEKLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
23,675 SEKMedian day 91,009 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
Simris Group AB logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
Frankfurt:5LU€0.0060 EUR+0.0020 (+50.0%)—€0.0030€0.0060€0.0030€0.0040Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · OMXSTO:SIMRIS_B · SEK, adjusted for splits

DayCloseChange%OpenHighLowVolume
0.087-0.009-9.0%0.0800.0950.08011,935
0.096+0.007+7.9%0.0990.0990.075165,816
0.089+0.002+2.3%0.0880.0890.08872,138
0.0870.000-0.5%0.0870.0870.070105,817
0.087+0.012+16.2%0.0990.0990.080376,619
0.075-0.020-20.8%0.0950.0960.0501,502,138
0.095-0.007-6.9%0.1100.1100.092305,591
0.102-0.010-8.5%0.1140.1140.102106,453
0.112-0.005-4.3%0.1150.1150.102132,424
0.117+0.003+2.2%0.1140.1180.101287,366
0.114-0.006-5.0%0.1180.1210.11447,443
0.120+0.001+0.8%0.1190.1280.1131,367,040
0.119+0.006+5.3%0.1130.1190.11325,935
0.113-0.008-6.6%0.1210.1210.11378,608
0.121-0.004-3.2%0.1210.1220.11124,887
0.125+0.004+2.9%0.1220.1250.11042,261
0.122+0.002+1.7%0.1150.1270.11339,412
0.120-0.002-1.6%0.1260.1260.11330,986
0.122-0.003-2.4%0.1240.1280.111254,667
0.125+0.006+5.1%0.1200.1380.110379,804
0.119-0.004-3.3%0.1270.1300.112247,602
0.123-0.004-3.2%0.1210.1250.120127,219
0.127+0.008+6.3%0.1190.1270.11940,109
0.119-0.009-7.0%0.1110.1280.111432,066
0.128+0.008+6.7%0.1290.1290.10924,604
0.120+0.001+0.4%0.1080.1470.108792,171
0.120-0.001-0.4%0.1200.1200.10822,251
0.120-0.003-2.0%0.1150.1220.108163,903
0.123+0.011+9.9%0.1210.1470.112982,568
0.112+0.004+3.7%0.1180.1200.108236,483
0.108-0.021-16.0%0.1200.1200.108227,983
0.128+0.016+14.3%0.1240.1400.107559,023
0.112-0.012-9.7%0.1240.1240.11254,549
0.124+0.014+12.7%0.1110.1240.111183,219
0.110-0.006-5.2%0.1240.1240.09970,288
0.116+0.002+1.8%0.1250.1270.1167,310
0.114-0.004-3.4%0.1100.1230.11056,863
0.118+0.013+12.9%0.1190.1190.103113,247
0.105+0.001+0.5%0.1100.1200.10582,086
0.104-0.014-11.9%0.1180.1180.102126,257
0.118+0.002+1.7%0.1250.1250.11618,319
0.116+0.001+0.9%0.1160.1250.116348,051
0.115+0.012+11.1%0.1180.1200.09881,557
0.104-0.014-11.9%0.1130.1190.09887,102
0.118+0.000+0.4%0.1180.1200.11755,548
0.117-0.002-2.1%0.1150.1190.09362,367
0.120+0.002+2.1%0.1190.1200.093164,359
0.117+0.007+6.4%0.1130.1200.100443,455
0.110+0.020+22.8%0.0900.1210.0901,334,855
0.090+0.003+3.7%0.0860.0900.0863,013
0.086-0.004-4.0%0.0900.0900.08646,937
0.090+0.000+0.2%0.0900.0900.086374,549
0.090+0.000+0.2%0.0900.1000.090388,790
0.090-0.005-5.1%0.0950.0950.086216,763
0.094-0.002-2.5%0.0940.0970.08631,863
0.097-0.002-2.0%0.0900.0990.08694,916
0.099+0.001+0.8%0.0980.0990.08659,272
0.098-0.001-1.4%0.0980.0990.08959,271
0.099+0.004+4.6%0.0920.1080.085146,216
0.095-0.005-5.0%0.1100.1100.09585,586
0.100+0.004+4.2%0.1000.1100.09681,048
0.096-0.004-3.6%0.1000.1000.09420,010
0.1000.000-0.2%0.1000.1000.09255,011
0.100+0.001+1.2%0.0870.1000.087249,744
0.099+0.006+6.7%0.0990.0990.09322,296
0.092+0.000+0.4%0.0990.0990.09212,727
Ticker
Stockholm:SIMRIS_B
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
Stockholm
Currency
SEK

What changed lately

Latest news

All Simris Group AB news

Simris Group AB on 6ix

Sector
Health care
Industry
Biotechnology
News releases
13 in the last 12 months · 21 in all · newest Jul 6, 2026 · oldest 2024

Where Simris Group AB is listed

ListingExchangeCountryCurrency
Stockholm:SIMRISB · Home listing · This pageStockholmSwedenSEK
Frankfurt:5LUFrankfurtGermanyEUR
gettex:5LUgettexGermanyEUR
Munich:5LUMunichGermanyEUR

Valuation

EV/sales 144× against a median of 4.8×: the highest of 6 Biotechnology companies shown. Statements: 4 quarters to Jun 30, 2026 · price Nov 20, 2026

Enterprise value
199.7M SEK
P/E
Loss
EV/sales
144×
EV/EBITDA
Negative EBITDA
Price/book
154×
Gross margin
Revenue too small
Operating margin
Revenue too small
Net margin
Revenue too small
Debt to equity
117×
Beta
No index for this market yet

Biotechnology: the 10 companies nearest in size, of 890 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Simris Group AB Class B · OMXSTO:SIMRIS_BUS$11.54MUS$19.53Mn/a144×n/a154×n/a117×n/a
BioCardia, Inc. · NASDAQ:BCDAUS$11.88MUS$10.22Mn/an/an/a14.2×n/a0.7×0.42
Xintela AB · OMXSTO:XINTUS$11.88MUS$11.81Mn/a39.8×n/an/an/an/an/a
Pluri Inc. · NASDAQ:PLURUS$11.85MUS$38.65Mn/a26.5×n/an/an/an/a0.53
Synlogic Inc · OTC:SYBXUS$11.76MUS$201,442n/an/an/a1.2×n/a0.0×0.50
Imugene Ltd · ASX:IMUUS$11.74MUS$14.16Mn/an/an/a2.0×n/a0.7×n/a
Radiopharm Theranostics Limited · ASX:RADUS$11.59MUS$8.85Mn/a4.8×n/a0.7×n/a0.0×n/a
Aelis Farma SA · EURONEXT:AELISUS$11.55MUS$9.09Mn/a4.0×n/a4.5×−308.7%1.9×n/a
Dyadic International, Inc. · NASDAQ:DYAIUS$11.51MUS$12.03Mn/a3.9×n/an/a−226.9%n/a1.12
Psyence Biomedical Ltd. · NASDAQ:PBMUS$11.33MUS$4.18Mn/an/an/a0.9×n/a0.0×0.90
Medicenna Therapeutics Corp. · TSX:MDNAUS$11.26MUS$7.37Mn/an/an/a9.7×n/a0.1×1.36
Median of the othersUS$11.66MUS$9.66M4.8×2.0×−267.8%0.1×0.72

Team and board

OfficerRole
Daniel KubitzaInterim CEO of Simris Group AB

Events

QuarterResultsShare move
Q1 2024Apr 5, 2024 · Before open−11.2%

Open Events

Financings

RaiseDateIn US dollars
Class B shares on exercise of warrants of series 2025/2027 and 2026/2027
Announced: €1 · SEK 0.05 a share
Jul 6, 2026US$1
Private placement of units consisting of class B shares and warrants
Update: SEK 0.05 a unit
Jan 19, 2026
Private placement of class B shares
Announced: SEK 0.05 a share
Insiders: Directed issue to managers who have entered into loan agreements with the Company
Jan 19, 2026

Open Financings · Read by 6ix AI from the company's releases

Financials

Annual, in SEK

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue1.61M2.89M4.35M4.08M6.14M2.17M1.74M761.8K851.6K726.2K
Cost of revenue33.0M1.67M2.35M4.82M8.20M4.92M3.13M1.06M-1.62M1.47M
Gross profit-31.3M1.22M2.01M-742.0K-2.07M-2.75M-1.39M-296.7K2.47M-741.8K
Research and development90.0K98.0K433.0K432.5K
Selling, general and administrative5.83M7.43M9.85M10.9M12.3M10.7M9.52M9.58M8.94M7.63M
Operating income-31.3M-34.7M-36.6M-24.7M-28.9M-23.7M-24.6M-22.7M-22.6M-18.8M
Depreciation and amortization14.0M14.9M14.3M6.65M2.92M3.03M3.13M3.48M3.48M1.59M
EBITDA-17.3M-19.8M-22.4M-18.0M-26.0M-20.7M-21.5M-19.2M-19.1M-17.2M
Interest expense441.0K3.50M3.99M1.11M616.0K1.84M2.38M1.32M354.3K570.3K
Income before tax-30.0M-38.2M-40.6M-25.8M-28.3M-25.5M-27.0M-24.0M-23.0M-19.3M
Income tax-3.19M-3.57M-3.32M-1.34M13.0K67.0K-94.0K-18.0K14.2K22.3K
Net income-26.8M-34.6M-37.3M-24.4M-28.4M-25.6M-26.9M-24.0M-23.0M-19.3M
Earnings per share, basic-0.03-0.10-0.16-0.16-0.24-0.23-1.20-0.97-1.14-1.04

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents1.47M1.95M5.67M3.99M961.0K16.5M7.86M4.42M7.43M32.1M
Receivables13.9M503.0K2.18M945.0K728.0K777.0K1.41M698.8K873.9K1.03M
Inventory1.08M509.0K1.09M2.26M3.35M8.82M10.9M9.96M7.39M2.30M
Current assets16.5M3.05M9.21M7.40M5.78M28.1M20.4M15.4M16.7M35.5M
Property, plant and equipment11.4M15.0M20.5M22.4M23.4M26.4M29.1M32.1M35.0M37.9M
Total assets148.4M157.1M174.6M185.7M29.2M57.1M52.2M49.8M54.4M76.4M
Accounts payable1.31M1.82M1.83M939.0K1.10M1.94M1.50M1.50M1.90M636.5K
Current liabilities25.0M16.0M14.3M23.9M9.09M6.92M13.8M5.66M5.88M4.60M
Long-term debt1.27M1.37M1.46M1.56M1.81M2.65M3.36M4.34M5.79M6.41M
Total debt87.7M2.04M2.67M2.13M3.13M3.99M4.70M5.69M6.72M7.23M
Total liabilities148.9M151.4M148.9M162.7M11.0M9.64M17.2M10.1M11.7M11.0M
Shareholders' equity-470.0K5.64M25.6M23.0M18.2M47.4M35.0M39.8M42.7M65.3M
Shares outstanding842.1M348.1M228.6M148.7M119.1M111.2M22.5M24.6M20.2M18.6M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations-16.0M-18.0M-36.4M-18.2M-18.1M-19.5M-17.3M-22.3M-23.6M-18.6M
Capital spending-16.0M-613.0K-1.61M-22.4M-253.0K-286.0K-356.0K-169.9K-301.1K-15.6M
Free cash flow-16.3M-18.6M-38.0M-40.6M-18.4M-19.8M-17.7M-22.4M-23.9M-34.2M
Cash from investing-224.0K-613.0K-1.61M-22.4M-253.0K-286.0K-356.0K-169.9K-301.1K-15.6M
Cash from financing15.8M14.9M39.6M43.6M2.84M28.4M21.1M19.4M-781.4K40.7M
Share buybacks13.9M39.3M28.1M201.0K36.9M22.1M21.1M337.8K46.0M
Change in cash-481.0K-3.72M1.67M3.03M-15.6M8.65M3.44M-3.01M-24.7M6.46M

Open Financials

Cap table

Built by 6ix from Simris Group AB Class B’s releases · as of Jul 6, 2026

Common shares
1,349,793,273
Fully diluted
1,349,793,273

Fully diluted

LineShares
Common shares1,349,793,273

Share count over time

CountShares
Nov 22, 20261,349,793,273

Open Cap table

Shareholders

TradeTradeSharesPriceValueDate
Jonathan Tyler Royce
Chairman of the Board of Directors
Buy207,542SEK 0.10SEK 20,173Mar 26, 2026
Royce CoLabs AB
Chairman of the Board of Directors
Sale207,542SEK 0.09SEK 19,177Mar 25, 2026
Jonathan Tyler Royce
Chairman of the Board of Directors
Buy222,581SEK 0.09SEK 20,967Mar 24, 2026
Royce CoLabs AB
Chairman of the Board of Directors
Sale222,581SEK 0.08SEK 18,697Mar 23, 2026
Magnus Högström
Member of the Board of Directors
Sale180,000SEK 0.11SEK 19,926Mar 10, 2026
Magnus Högström
Member of the Board of Directors
Sale150,000SEK 0.11SEK 16,871Mar 9, 2026

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Daniel KubitzaInterim CEO of Simris Group AB · Since at least Jul 6, 2026

Open People

Log in to ask 6ix AI your own questions about Simris Group AB.